The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Phenylpropanolamine 25 mgThis page contains information on Phenylpropanolamine 25 mg for veterinary use.
The information provided typically includes the following:
- Phenylpropanolamine 25 mg Indications
- Warnings and cautions for Phenylpropanolamine 25 mg
- Direction and dosage information for Phenylpropanolamine 25 mg
Phenylpropanolamine 25 MgThis treatment applies to the following species:
25 Mg Chewable Tablets
for Use In Dogs Only
cautionFederal law restricts this drug to use by or on the order of a licensed veterinarian.
PPA chewable tablets contain 25 mg of phenylpropanolamine hydrochloride. Phenylpropanolamine is an α-adrenergic agonist which has been shown to increase urethral sphincter pressure in dogs. Loss of urethral sphincter tone and decreased sphincter pressure is associated with urinary incontinence in ovariohysterectomized or anestrous dogs.
Phenylpropanolamine 25 mg Indications
PPA is indicated for the control of urinary incontinence caused by urethral sphincter incompetence in female dogs.
Dosage & Administration
The recommended dose of PPA is 3 mg per kg body weight per day, divided into two or three equal oral doses. Some patients may achieve an adequate clinical response with a lower dose. Dosage may be rounded to the nearest 6.25 mg for practical dosing.
Not for human use. Keep this and all drugs out of reach of children. PPA should be avoided or used cautiously in dogs with glaucoma, cardiac disease, hypertension, renal insufficiency, and diabetes mellitus.
PPA should not be administered with other sympathomimetic drugs or tricyclic antidepressants, nor within two weeks of a monoamine oxidase inhibitor because of the risk of acute hypertension. PPA may increase the risk of cardiac arrhythmias from halogenated gaseous anesthetics. Possible side effects include restlessness, irritability, tachycardia, hypertension, and anorexia. It may take several days for the full benefit of the drug to be seen. Missed doses may negate the desired effect.
Adverse reactions related to administration of PPA may include restlessness, irritability, tachycardia, hypertension, urinary retention and anorexia.
Store between 2°-30°C (36°-86°F). Keep container tightly closed.
For use in animals only.
Distributed by: MWI, Meridian, ID 83680
MADE IN USA
Distributed by MWI Veterinary Supply
651 S. STRATFORD DRIVE, SUITE 100, MERIDIAN, ID, 83642
|Every effort has been made to ensure the accuracy of the Phenylpropanolamine 25 mg information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Phenylpropanolamine 25 mg product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-08-31